Tumor cells of epithelial origin present rampant DNA damage but do not undergo apoptosis due to inactivation of TP53. Understanding the mechanisms by which tumor cells are protected from cell death is crucial for identifying new therapeutic targets. Cottini et al. report that hematological malignancies also present DNA damage and a distinct, TP53-independent mechanism for evading cell death: low levels of the Hippo pathway coactivator YAP1 prevent apoptosis induced by nuclear relocalization of ABL1 triggered by DNA damage. A serine-threonine kinase, STK4, downregulates YAP1 levels; notably, STK4 inhibition increases YAP1 and related p73-mediated apoptosis in hematological malignancies.
- Francesca Cottini
- Teru Hideshima
- Giovanni Tonon